|
IT1304406B1
(it)
*
|
1998-10-21 |
2001-03-19 |
Danital Italia S R L |
Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
|
|
CA2260397A1
(en)
|
1999-01-29 |
2000-07-29 |
Atlantis Marine Inc. |
Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
|
|
PT102509A
(pt)
*
|
2000-08-16 |
2002-02-28 |
Fundacao Essprit Icarus |
Composicoes farmaceuticas, cosmeticas e dermo-cosmeticas, de higiene, alimentares e para-alimentares a base de oleo de foca, e sua utilizacao
|
|
JP5000035B2
(ja)
*
|
2000-09-04 |
2012-08-15 |
株式会社スピルリナ研究所 |
ドコサペンタエン酸含有グリセリドの製造方法
|
|
WO2003003855A1
(de)
*
|
2001-07-05 |
2003-01-16 |
Luedke Hans-Werner |
Nahrungsergänzungsprodukt oder arzneimittel gegen bestimmte mangelzustände und hirnfunktionsstörungen
|
|
DK1417211T3
(da)
|
2001-07-27 |
2007-10-08 |
Neptune Technologies & Bioress |
Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse
|
|
WO2003055323A1
(en)
*
|
2001-12-27 |
2003-07-10 |
Genesis Group Inc. |
Seal oil based lipid emulsions and uses thereof
|
|
WO2003092628A2
(en)
|
2002-05-03 |
2003-11-13 |
Martek Biosciences Corporation |
High-quality lipids and methods for producing by enzymatic liberation from biomass
|
|
EP2295529B2
(en)
|
2002-07-11 |
2022-05-18 |
Basf As |
Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
|
|
SE0202188D0
(sv)
|
2002-07-11 |
2002-07-11 |
Pronova Biocare As |
A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
|
|
CA2499501A1
(en)
*
|
2002-09-27 |
2004-04-08 |
Martek Biosciences Corporation |
Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
|
|
EP2384750A1
(en)
*
|
2002-09-27 |
2011-11-09 |
Martek Biosciences Corporation |
Improved Glycemic Control for Prediabetes and/or Diabetes Type II using Docohexaenoic Acid
|
|
ATE430802T1
(de)
|
2003-08-21 |
2009-05-15 |
Monsanto Technology Llc |
Fettsäuredesaturasen aus primula
|
|
JP4699901B2
(ja)
*
|
2003-09-02 |
2011-06-15 |
ジェレックスインターナショナル株式会社 |
体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質
|
|
ITMI20032247A1
(it)
*
|
2003-11-19 |
2005-05-20 |
Tiberio Bruzzese |
Interazione di derivati polari di composti insaturi con substrati inorganici
|
|
BRPI0509944A
(pt)
|
2004-04-16 |
2007-09-25 |
Monsanto Technology Llc |
expressão de dessaturases de ácido graxo em milho
|
|
TWI397582B
(zh)
|
2004-11-04 |
2013-06-01 |
Monsanto Technology Llc |
油組合物之製備方法
|
|
PE20070482A1
(es)
*
|
2005-08-26 |
2007-06-08 |
Ocean Nutrition Canada Ltd |
Metodo para remover y/o reducir esteroles a partir de aceites
|
|
US7977498B2
(en)
|
2005-08-26 |
2011-07-12 |
Ocean Nutrition Canada Limited |
Reduction of sterols and other compounds from oils
|
|
MX2008003213A
(es)
*
|
2005-09-09 |
2008-03-18 |
Kellog Co |
Acidos grasos omega-3 encapsulados en recubrimientos de zeina y productos alimenticios que los incorporan.
|
|
US7867538B2
(en)
|
2005-12-20 |
2011-01-11 |
Archer Daniels Midland Company |
Processes of improving the quality of oil and products produced therefrom
|
|
AU2007226680B2
(en)
|
2006-03-10 |
2013-10-24 |
Monsanto Technology Llc |
Soybean seed and oil compositions and methods of making same
|
|
TW200820913A
(en)
*
|
2006-08-25 |
2008-05-16 |
Martek Biosciences Corp |
Food fortification with polyunsaturated fatty acids
|
|
US20090162525A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Tropicana Products, Inc. |
Food product including one or more encapsulated omega-3 fatty acids and one or more fruit flavors
|
|
WO2009102558A2
(en)
*
|
2008-02-11 |
2009-08-20 |
Monsanto Technology Llc |
Aquaculture feed, products, and methods comprising beneficial fatty acids
|
|
WO2009132463A1
(en)
*
|
2008-05-02 |
2009-11-05 |
Neptune Technologies & Bioressources Inc. |
New deodorization method and organoleptic improvement of marine oil extracts
|
|
JP6113954B2
(ja)
|
2008-10-31 |
2017-04-12 |
リピッド ファーマシューティカルズ イーエイチエフ. |
医薬として使用するための脂肪酸
|
|
DE102008060059A1
(de)
*
|
2008-12-02 |
2010-06-10 |
Süd-Chemie AG |
Verfahren zur Reduzierung des 3-MCPD-Gehalts in raffinierten Pflanzenölen
|
|
SG175390A1
(en)
|
2009-04-29 |
2011-12-29 |
Amarin Corp Plc |
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
|
|
PT3278665T
(pt)
|
2009-04-29 |
2020-11-19 |
Amarin Pharmaceuticals Ie Ltd |
Composição farmacêutica estável e métodos de utilização das mesmas
|
|
CN106074486A
(zh)
|
2009-06-15 |
2016-11-09 |
阿马里纳药物爱尔兰有限公司 |
在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl‑c水平的组合物和方法
|
|
US9480271B2
(en)
|
2009-09-15 |
2016-11-01 |
Monsanto Technology Llc |
Soybean seed and oil compositions and methods of making same
|
|
US20110071176A1
(en)
|
2009-09-23 |
2011-03-24 |
Amarin Pharma, Inc. |
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
|
|
WO2011050474A1
(en)
|
2009-10-29 |
2011-05-05 |
Acasti Pharma, Inc. |
Concentrated therapeutic phospholipid compositions
|
|
EP2366766B8
(en)
*
|
2010-03-09 |
2017-04-19 |
Stepan Specialty Products, LLC |
Method of treating an edible oil and oil thus obtained
|
|
SG10202010355PA
(en)
|
2010-03-12 |
2020-11-27 |
Berg Llc |
Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
|
|
CN103124791B
(zh)
|
2010-06-01 |
2016-08-24 |
帝斯曼知识产权资产管理有限公司 |
从细胞中提取脂质以及由此获得的产品
|
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
NZ778131A
(en)
|
2010-11-29 |
2023-03-31 |
Amarin Pharmaceuticals Ie Ltd |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
|
EP2720680B1
(en)
|
2011-06-17 |
2020-02-12 |
Berg LLC |
Inhalable pharmaceutical compositions
|
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
|
EP2775837A4
(en)
|
2011-11-07 |
2015-10-28 |
Amarin Pharmaceuticals Ie Ltd |
METHODS OF TREATING HYPERTRIGLYCERIDEMIA
|
|
ES2891473T3
(es)
|
2012-01-06 |
2022-01-28 |
Amarin Pharmaceuticals Ie Ltd |
Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
|
|
EP4338805B1
(en)
|
2012-06-29 |
2025-06-04 |
Amarin Pharmaceuticals Ireland Limited |
Eicosapentaenoic acid ethyl ester for use in reducing the risk of non-fatal myocardial infarction in a subject on statin therapy
|
|
CA2878434C
(en)
*
|
2012-07-31 |
2020-11-10 |
Dsm Nutritional Products Ag |
Refinement of oils using green tea extract antioxidants
|
|
WO2014074552A2
(en)
|
2012-11-06 |
2014-05-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
|
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
|
US9877944B2
(en)
|
2013-04-22 |
2018-01-30 |
Smartfish As |
Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
|
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
|
CN103881801A
(zh)
*
|
2013-10-27 |
2014-06-25 |
刘跃 |
取消精炼工序并能有效降低食用油中水分的方法
|
|
AU2014369042B2
(en)
|
2013-12-20 |
2020-04-30 |
Dsm Ip Assets B.V. |
Processes for obtaining microbial oil from microbial cells
|
|
NZ721409A
(en)
|
2013-12-20 |
2022-10-28 |
Dsm Ip Assets Bv |
Processes for obtaining microbial oil from microbial cells
|
|
WO2015095693A2
(en)
|
2013-12-20 |
2015-06-25 |
Dsm Ip Assets B.V. |
Processes for obtaining microbial oil from microbial cells
|
|
PL3082793T3
(pl)
|
2013-12-20 |
2020-10-05 |
Dsm Ip Assets B.V. |
Sposoby otrzymywania oleju drobnoustrojowego z komórek drobnoustrojowych
|
|
SG11201605043TA
(en)
|
2013-12-20 |
2016-07-28 |
Dsm Ip Assets Bv |
Processes for obtaining microbial oil from microbial cells
|
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
|
WO2015195662A1
(en)
|
2014-06-16 |
2015-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
|
|
JP6967334B2
(ja)
*
|
2015-12-21 |
2021-11-17 |
備前化成株式会社 |
高度不飽和脂肪酸のエステルを含む組成物
|
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
|
WO2018213663A1
(en)
|
2017-05-19 |
2018-11-22 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject having reduced kidney function
|
|
CN107746747A
(zh)
*
|
2017-11-08 |
2018-03-02 |
厦门汇盛生物有限公司 |
一种降低多不饱和脂肪酸油过氧化值和茴香胺值的方法
|
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
|
KR20210110890A
(ko)
|
2018-09-24 |
2021-09-09 |
애머린 파마슈티칼스 아일랜드 리미티드 |
대상체에서 심혈관 사건의 위험도를 감소시키는 방법
|
|
KR102943980B1
(ko)
*
|
2018-12-14 |
2026-03-26 |
디에스엠 아이피 어셋츠 비.브이. |
증진된 기호성을 갖는 다불포화 지방산 함유 식품 성분, 및 이의 제조 방법
|
|
US12427134B2
(en)
|
2019-11-12 |
2025-09-30 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of cardiovascular events in a subject with atrial fibrillation and/or atrial flutter
|
|
AU2022263358A1
(en)
|
2021-04-21 |
2023-11-30 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing the risk of heart failure
|
|
EP4586824A1
(en)
*
|
2022-09-14 |
2025-07-23 |
Société des Produits Nestlé S.A. |
Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
|
|
WO2025145410A1
(en)
*
|
2024-01-05 |
2025-07-10 |
Cargill, Incorporated |
Methods of refining liquid oil and controlling p-anisidine value
|